Zung Self-Rating Depression Scale (ZUNG)

1. Abstract

The Zung Self-Rating Depression Scale (ZUNG SDS) is a widely utilized 20-item self-report questionnaire designed to quantify the severity of depressive symptomatology in adults. Developed by psychiatrist William W. K. Zung in 1965 at Duke University Medical Center, the instrument operationalizes the clinical and diagnostic characteristics of major depressive disorder across four established clinical dimensions: core depressive affect, cognitive disturbances, anxiety-related manifestations, and somatic/physiological alterations. The instrument comprises an even split of 10 positively phrased (symptom-free) items that require reverse scoring and 10 negatively phrased (symptom-present) items scored directly on a 4-point Likert-type scale ranging from 1 (“A little of the time”) to 4 (“Most or all of the time”). Raw scores range from 20 to 80, with clinical cut-offs established to classify patients into normal affective status (20–49), mild depression (50–59), moderate depression (60–69), and severe depression (70 and above), or converted to the traditional Zung Depression Index ranging from 0.25 to 1.00.

Extensive psychometric evaluations over six decades have confirmed the scale’s robust reliability and validity across clinical inpatients, outpatients, community populations, and geriatric cohorts. Internal consistency estimates systematically yield Cronbach’s alpha coefficients between 0.79 and 0.92, accompanied by split-half reliability coefficients exceeding 0.73. Factor analytic investigations, including primary care and psychiatric outpatient studies, delineate a solid four-factor structure (core depressive factor, cognitive factor, anxiety factor, and somatic factor) exhibiting coefficients of congruence up to 0.98. The scale demonstrates profound convergent validity with interviewer-administered measures such as the Hamilton Rating Scale for Depression (HAM-D) and self-report metrics like the Beck Depression Inventory (BDI). This article provides a comprehensive academic overview of the instrument’s theoretical rationale, structural composition, statistical properties, diagnostic interpretation, and empirical administration guidelines.

2. Keywords

Zung Self-Rating Depression Scale, ZUNG SDS, depression assessment, affective disorders, psychometrics, somatic depression symptoms, internal consistency, factor structure, psychiatric epidemiology, clinical rating scales

3. Authors

The scale was developed and established by William W. K. Zung, M.D. (1929–1992), who was a prominent psychiatrist and Professor of Psychiatry at the Duke University Medical Center and the Veterans Administration Hospital in Durham, North Carolina, United States. Dr. Zung was a pioneer in quantitative clinical psychiatric assessments, psychopharmacology, and cross-cultural affective research. Over his academic career, he contributed foundational work on the measurement of depressive states, anxiety manifestations (culminating in the companion Zung Self-Rating Anxiety Scale [SAS]), and sleep electroencephalography abnormalities associated with clinical depression.

Subsequent psychometric cross-validation, normative standardization, and structural validation have been conducted by numerous international psychiatric researchers, including significant contributions by R. G. Knight, H. J. Waal-Manning, and G. F. S. Spears (University of Otago, New Zealand) regarding community and elderly populations, as well as I. Romera, H. Delgado-Cohen, T. Perez, L. Caballero, and I. Gilaberte regarding primary care multidimensional factor congruence.

4. Purpose

The fundamental purpose of the Zung Self-Rating Depression Scale is to provide a brief, psychometrically sound, standardized quantitative index of affective illness severity based on clinical diagnostic criteria. When Dr. Zung formulated the instrument in 1965, existing assessment methodologies were heavily tilted toward lengthy clinician-rated interviews, such as the Hamilton Rating Scale for Depression (HAM-D), or broad, non-specific personality inventories that suffered from excessive administration burdens and substantial training overheads. The SDS was explicitly engineered to yield an objective self-administered profile that accurately captures the multidimensional presentation of clinical depression without placing an undue burden on distressed patients.

Clinical and Diagnostic Applications

In clinical psychiatric settings, primary care, and general medicine, the ZUNG SDS serves three primary functional utilities:

• Screening and Case Identification: The scale acts as an efficient triage instrument to detect undetected depressive disorders in primary healthcare, general hospital medical-surgical wards, and community health centers. Because depressive disorders frequently present with somatic disguises (e.g., fatigue, gastrointestinal complaints, sleep fragmentation), the deliberate inclusion of neurovegetative items prevents false-negative determinations.
• Quantifying Depressive Severity: Unlike categorical diagnostic tools that simply dichotomize individuals into “depressed” or “non-depressed,” the SDS measures the continuum of severity from normal baseline variations to severe, debilitating affective pathology.
• Treatment Monitoring and Longitudinal Response: The sensitivity of the SDS to therapeutic change makes it highly suitable for tracking symptom reduction over the course of pharmacotherapy (antidepressants), cognitive-behavioral interventions, or electroconvulsive therapy (ECT). Repeated weekly or biweekly administrations provide quantitative verification of clinical response, partial remission, or refractory stagnation.

Research Applications

In clinical trials and psychiatric epidemiology, the SDS serves as an established primary or secondary outcome measure. It enables researchers to standardize affective symptom severity across international cohorts, evaluate the relative efficacy of novel psychotropic compounds, and explore epidemiological correlates of mood disturbance in relation to cardiovascular disease, stroke rehabilitation, diabetes, chronic pain syndromes, and oncology. Furthermore, its balanced inclusion of affective, cognitive, somatic, and psychomotor symptoms allows researchers to examine differential symptom-cluster responses to targeted pharmacological or psychological interventions.

5. Psychological Construct

The construct operationalized by the Zung Self-Rating Depression Scale is clinical depression, conceived as an encompassing affective, cognitive, somatic, and behavioral syndrome. Zung identified that a psychometrically valid depression index must avoid conceptual reductionism: it cannot focus exclusively on negative subjective mood (affect) while disregarding the profound autonomic, biological, and cognitive disintegrations that characterize the condition. Grounded in systematic clinical psychiatric formulations, the scale assesses four central symptomatic domains:

1. Core Depressive Factor (Pervasive Affect & Anhedonia)

This central dimension reflects the fundamental emotional core of mood disturbance: sustained dysphoria, affective flattening, crying spells, anhedonia, and demoralization. Depressive affect involves not merely transient sadness, but a pervasive, unyielding despondency (“feeling down-hearted and blue”). Furthermore, the construct incorporates the profound loss of interest and pleasure in life activities (anhedonia), spanning recreational pursuits, interpersonal engagements, and sexual drive. At its most severe, this domain encompasses existential despair, characterized by the belief that life has lost meaning and that others would be better off if the individual were dead.

2. Cognitive Factor (Psychomotor Retardation & Executive Dysfunction)

The cognitive dimension of depression involves subjective alterations in executive processing, attentional capacity, mental clarity, and perceived personal utility. Patients experiencing depressive episodes frequently describe severe cognitive slowing (“brain fog”), indecisiveness, and a striking inability to execute everyday tasks that were previously routine. In the ZUNG framework, this factor captures:

• Subjective cognitive efficiency and mental clarity (Item 11: “My mind is as clear as it used to be”).
• Executive functioning, initiation, and decision-making ease (Item 16: “I find it easy to make decisions”).
• Perceived self-worth, utility, and social purpose (Item 17: “I feel that I am useful and needed”).
• General energy mobilization to complete daily activities (Item 12: “I find it easy to do the things I used to”).

3. Anxiety Factor (Psychomotor Agitation & Irritability)

Recognizing the high rate of clinical co-occurrence between affective collapse and psychological distress, Zung incorporated markers of internal tension, motor restlessness, and affective lability. This factor encompasses psychomotor agitation, manifest as a subjective inability to sit still, motor pacing, and physical restlessness (Item 13: “I am restless and can’t keep still”), alongside marked affective irritability (Item 15) and nocturnal insomnia (Item 4). These features frequently correspond to agitated depressive subtypes or mixed affective states.

4. Somatic and Physiological Factor (Biological Vegetative Functions)

A distinctive hallmark of the ZUNG SDS is its explicit representation of the neurovegetative and neuroendocrine symptoms of depression. Zung posited that biological symptoms are intrinsic expressions of hypothalamic-pituitary-adrenal axis dysregulation and autonomic nervous system imbalance. This dimension measures:

• Diurnal Affective Variation: Pathognomonic morning worsening vs. morning elevation of mood (Item 2).
• Appetite and Metabolic Homeostasis: Anorexia, objective decrease in food consumption, and involuntary weight loss (Items 5 and 7).
• Autonomic/Gastrointestinal Regulation: Tachycardia (“My heart beats faster than usual”, Item 9) and decreased intestinal motility (“trouble with constipation”, Item 8).
• Anergia: Pervasive, unprovoked physical exhaustion and lethargy (Item 10).

6. Theoretical Framework

The theoretical framework underpinning the Zung Self-Rating Depression Scale is rooted in mid-twentieth-century phenomenological psychiatry and the early biological models of affective disease. Unlike psychoanalytic frameworks that conceptualized depression primarily in terms of retroflexed rage, unconscious loss, or structural superego punishment, Zung adopted an empirical, symptom-oriented psychiatric paradigm influenced by Adolf Meyer’s psychobiology and the descriptive psychopathology of Emil Kraepelin and Kurt Schneider.

The Phenomenological-Diagnostic Foundation

Zung sought to build an assessment instrument directly aligned with observed clinical psychopathology. In the 1960s, clinical consensus categorized depressive states through observable signs and patient-reported symptoms across three cardinal functional domains: pervasive affective disturbances, physiological/vegetative dysfunctions, and psychological/cognitive distortions. Zung operationalized these clinical dimensions so that each individual item mapped directly to documented psychiatric diagnostic criteria.

Psychometric Measurement Theory and Methodological Design

From a psychometric measurement perspective, Zung recognized that self-report questionnaires are vulnerable to response styles, such as acquiescence bias (the tendency to systematically agree with items regardless of content). To counteract this artifact, Zung designed the SDS with an exact 50/50 balance between symptom-present (negatively keyed) and symptom-absent (positively keyed) statements. Ten items are worded positively to indicate affective well-being and adaptive functioning, requiring reverse scoring, while ten items are worded negatively to indicate manifest distress. This deliberate structural balancing compels the respondent to process each statement thoughtfully rather than endorsing a uniform pattern down the questionnaire page.

7. Validity

The construct, criterion, convergent, and discriminant validity of the Zung Self-Rating Depression Scale have been confirmed across hundreds of empirical studies spanning psychiatric clinics, general medical practices, geriatric facilities, and cross-cultural cohorts.

Construct and Discriminant Validity

In his initial validation investigation, Zung (1965) administered the scale to 56 admitted psychiatric inpatients with a primary diagnosis of depressive disorder and compared their scores to 100 control subjects without psychiatric diagnoses (hospital staff, medical students, and community volunteers). The depressed group demonstrated a mean raw total score of 59.2 (corresponding to a Zung SDS index of 0.74; standard deviation = 8.8), whereas the non-depressed control cohort exhibited a mean raw score of 26.4 (SDS index of 0.33; standard deviation = 6.4). The differences between the diagnostic groups were statistically significant (p < .0001), establishing clear separation between clinical and non-clinical affective profiles.

Further diagnostic discrimination studies conducted by Guy (1976) across 209 psychiatric patients demonstrated differential mean total scores across diagnostic categories: depressive disorders averaged 65 (n = 96), personality disorders averaged 56 (n = 54), generalized anxiety disorders averaged 53 (n = 22), schizophrenia averaged 52 (n = 25), and transient situational adjustment disorders averaged 48 (n = 12). While this demonstrates that individuals with various psychiatric disorders endorse some degree of distress, the scale demonstrates robust sensitivity and clinical elevation specifically for depressive disorders.

Convergent Validity

The convergent validity of the SDS has been evaluated against interviewer-rated psychiatric evaluations and validated self-report instruments:

• Correlation with the Hamilton Rating Scale for Depression (HAM-D): Multiple investigations have identified strong positive correlations between the ZUNG SDS and the clinician-administered HAM-D, typically ranging between r = 0.65 and r = 0.82 (Zung, 1969; Biggs et al., 1978).
• Correlation with the Beck Depression Inventory (BDI): Cross-comparative studies in clinical outpatient samples consistently demonstrate strong correlations between ZUNG SDS raw scores and BDI total scores, with Pearson coefficients ranging from r = 0.73 to r = 0.86.
• Correlation with the Minnesota Multiphasic Personality Inventory (MMPI): Zung (1967) demonstrated that the SDS index correlated highly with the MMPI Depression clinical scale (Scale 2; r = 0.70), confirming convergence with multidimensional objective personality batteries.

Criterion and Predictive Validity

In evaluating the diagnostic classification performance of the SDS using modern receiver operating characteristic (ROC) curves against structured DSM and ICD clinical diagnostic interviews, the instrument consistently achieves area under the curve (AUC) metrics between 0.84 and 0.93. When utilizing the standard clinical cut-off score of 50 (or an index score of 0.50 / total raw score of 40 in some modified research thresholds), sensitivity for detecting major depressive episodes ranges between 85% and 94%, with specificity hovering between 75% and 88%, establishing its utility as an epidemiological and clinical case identification tool.

8. Reliability

The reliability of the Zung Self-Rating Depression Scale has been established through internal consistency assessments, split-half correlations, and test-retest examinations across clinical and non-clinical cohorts.

Internal Consistency

Extensive normative and epidemiological research confirms high internal consistency for the instrument:

• In a comprehensive validation study by Knight, Waal-Manning, and Spears (1983) surveying a non-clinical community sample of 1,173 adult New Zealanders, the SDS achieved a satisfactory overall Cronbach’s alpha coefficient of 0.79.
• Clinical psychiatric studies with adult outpatients and inpatients diagnosed with Major Depressive Disorder (MDD) report Cronbach’s alpha values typically ranging between 0.84 and 0.92, indicating high internal coherence without item redundancy.
• In large primary care samples (e.g., Romera et al., 2008; N = 1,049), the total scale internal consistency demonstrated an alpha of 0.88, with individual subscales demonstrating varying internal consistencies: Core Depressive Factor (α = 0.82), Cognitive Factor (α = 0.73), Anxiety Factor (α = 0.68), and Somatic Factor (α = 0.64).

Split-Half and Test-Retest Reliability

Zung (1972) evaluated split-half reliability utilizing the Spearman-Brown prophecy formula in an operational psychiatric inpatient sample, finding a correlation coefficient of r = 0.73. Test-retest reliability evaluations demonstrate temporal stability when administered over short non-treatment intervals (1 to 2 weeks), with test-retest correlation coefficients consistently ranging from r = 0.81 to r = 0.89. Over longer intervals during clinical intervention, test-retest correlations decrease, reflecting the instrument’s sensitivity to symptom change.

9. Factor Analysis

The underlying latent dimensional structure of the ZUNG SDS has been extensively investigated via both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA). Although Zung initially constructed the scale based on clinical face validity reflecting a single generalized construct of affective disorder, subsequent empirical structural analyses have consistently revealed an underlying multidimensional architecture.

The Four-Factor Empirical Structure

The most widely replicated and validated structural model of the SDS is the four-factor framework confirmed by Romera et al. (2008) in a nationwide cohort of 1,049 primary care patients presenting with major depressive disorder. Using principal component analysis followed by varimax and oblimin rotations, the authors identified four clear symptomatic dimensions that accounted for over 52% of the total variance, demonstrating high Tucker-Lewis coefficients of congruence (0.98, 0.95, 0.92, and 0.87 for factors I, II, III, and IV, respectively):

Confirmatory Factor Analysis & Fit Indices

Modern structural equation modeling (SEM) evaluating the four-factor model against alternative unidimensional and hierarchical models indicates superior fit for the four-factor solution across adult and geriatric samples. Typical confirmatory fit indices meet conventional psychometric standards:

• Comparative Fit Index (CFI): 0.94 – 0.96
• Tucker-Lewis Index (TLI): 0.93 – 0.95
• Root Mean Square Error of Approximation (RMSEA): 0.042 – 0.055 (90% CI [0.038, 0.061])
• Standardized Root Mean Square Residual (SRMR): 0.039 – 0.048

10. Instrument / Measurement Tool

• Instrument Name: Zung Self-Rating Depression Scale (ZUNG SDS)
• Assessment Type: Self-report questionnaire / quantitative rating scale
• Target Population: Adults (aged 18 and older); validated adaptations available for adolescents (16+) and geriatric populations
• Administration Time: Approximately 5 to 10 minutes
• Item Count: 20 items
• Response Format: 4-point Likert-type scale: 1 = A little of the time, 2 = Some of the time, 3 = A good part of the time, 4 = Most or all of the time
• Scoring Procedures:
  • Direct Scoring (Symptom-Present Items): Items 1, 3, 4, 7, 8, 9, 10, 13, 15, and 19 are scored directly from 1 to 4:
    1 = A little of the time, 2 = Some of the time, 3 = A good part of the time, 4 = Most or all of the time.
  • Reverse Scoring (Symptom-Free Items): Items 2, 5, 6, 11, 12, 14, 16, 17, 18, and 20 are reverse-scored from 4 to 1:
    4 = A little of the time, 3 = Some of the time, 2 = A good part of the time, 1 = Most or all of the time.
  • Total Raw Score: Sum of all 20 items. Scores range from a minimum of 20 to a maximum of 80.
  • Zung Depression Index Calculation (Alternative Method): The raw score is divided by the maximum possible score (80) and multiplied by 100 (or expressed as a decimal ranging from 0.25 to 1.00).
• Clinical Severity Cut-Off Score Ranges:
  • 20 – 49: Normal Range / Absence of significant depressive psychopathology
  • 50 – 59: Mildly Depressed
  • 60 – 69: Moderately Depressed
  • 70 and above: Severely Depressed
• Validated Subscale Scoring:
  • Core Depressive Factor: Items 1, 3, 6, 14, 17, 18, 19, 20 (Score range: 8 – 32)
  • Cognitive Factor: Items 10, 11, 12, 16 (Score range: 4 – 16)
  • Anxiety Factor: Items 4, 13, 15 (Score range: 3 – 12)
  • Somatic Factor: Items 5, 7, 9 (Score range: 3 – 12)
  • (Note: Item 8 [constipation] is retained within total score calculations but shows variable factor loading across empirical models).

11. Permissions & Fee and Test Year

The Zung Self-Rating Depression Scale was originally developed and published in 1965 by Dr. William W. K. Zung in the Archives of General Psychiatry (now JAMA Psychiatry). Having been published in 1965 without subsequent private corporate licensing restrictions, the instrument is generally considered to be in the public domain for clinical, academic, and non-commercial educational research purposes.

Researchers and clinical practitioners may reproduce and administer the scale without paying per-use royalty fees, provided that appropriate scholarly attribution is accorded to the original developer (Zung, 1965) and the source publication. For commercial applications, pharmaceutical industry clinical trials, or commercial software integration, institutional users should verify copyright status and clearance via the original journal publisher (American Medical Association).

12. References

Biggs, J. T., Wylie, L. T., & Ziegler, V. E. (1978). Validity of the Zung Self-Rating Depression Scale. The British Journal of Psychiatry, 132(4), 381–385. https://doi.org/10.1192/bjp.132.4.381

Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology (DHEW Publication No. ADM 76-338). National Institute of Mental Health, Psychopharmacology Research Branch.

Knight, R. G., Waal-Manning, H. J., & Spears, G. F. S. (1983). Some norms and reliability data for the State-Trait Anxiety Inventory and the Zung Self-Rating Depression scale. British Journal of Clinical Psychology, 22(4), 245–249. https://doi.org/10.1111/j.2044-8260.1983.tb00610.x

Romera, I., Delgado-Cohen, H., Perez, T., Caballero, L., & Gilaberte, I. (2008). Factor analysis of the Zung self-rating depression scale in a large sample of patients with major depressive disorder in primary care. BMC Psychiatry, 8, Article 4. https://doi.org/10.1186/1471-244X-8-4

Zung, W. W. K. (1965). A self-rating depression scale. Archives of General Psychiatry, 12(1), 63–70. https://doi.org/10.1001/archpsyc.1965.01720310065008

Zung, W. W. K. (1967). Factors influencing the self-rating depression scale. Archives of General Psychiatry, 16(5), 543–547. https://doi.org/10.1001/archpsyc.1967.01730230027004

Zung, W. W. K. (1969). A cross-cultural survey of symptoms in depression. The American Journal of Psychiatry, 126(1), 116–121. https://doi.org/10.1176/ajp.126.1.116

Zung, W. W. K. (1972). The Depression Status Inventory: An adjunct to the Self-Rating Depression Scale. Journal of Clinical Psychology, 28(4), 539–543. https://doi.org/10.1300/J018v05n01_08

13. Items of the Scale